| NCT ID | NCT05634928 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Soochow University |
| Condition | Thrombotic Microangiopathies |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-12-01 |
| Primary Completion | 2027-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-12-01 with a primary completion date of 2027-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Dec 1, 2022, to Nov 31, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical-related data of thrombotic microangiopathy.
Eligibility Criteria
Inclusion Criteria: * The patient has elevated lactate dehydrogenase to more than twice the baseline value, platelets less than 20 or decreased by more than 50% within 24 hours, and more than 2% of schistocytes visible on a peripheral blood smear. Alternatively, pathological sections show extensive micro thrombosis. Exclusion Criteria: * The investigator considers the subject unable or unwilling to cooperate with the study procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05634928 clinical trial?
This trial is open to participants of all sexes, studying Thrombotic Microangiopathies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05634928 currently recruiting?
Yes, NCT05634928 is actively recruiting participants. Contact the research team at hanyue@suda.edu.cn for enrollment information.
Where is the NCT05634928 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT05634928 clinical trial?
NCT05634928 is sponsored by The First Affiliated Hospital of Soochow University. The trial plans to enroll 500 participants.